BS
Therapeutic Areas
Adial Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AD04 | Alcohol Use Disorder (AUD) in genetically targeted patients | Phase 3 |
Leadership Team at Adial Pharmaceuticals
CJ
Cary J. Claiborne
Chief Executive Officer
TG
Tony Goodman
Chief Operating Officer
VS
Vinay Shah
Chief Financial Officer
BR
Brigitte Robertson, MD
Acting Chief Medical Officer
JR
John R. Martin, J.D.
Chief Legal Officer
AS
Abel Svitavsky, CPA
Controller
KS
Kevin Schuyler
Chairman of the Board
JK
J. Kermit Anderson
Member, Board of Directors
RG
Robertson Gilliland
Member, Board of Directors
DB
Dr. Bankhole Johnson
Co-founder, Pioneering Researcher